No correlation was found between miR-21 and potential markers of increased intestinal barrier permeability, such as LBP and DAO, which suggests that the role of miR-21 in MASLD development is multifactorial, and its association with intestinal permeability dysfunction in MASLD is less pronounced. The gene discussed is LBP; the disease is metabolic dysfunction-associated steatotic liver disease.